Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine

Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine

US Patent 7851599 · Granted Dec 14, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-αβTCR antibody2021
Methods for enhancing immunosuppressive therapy by multiple administration of αβ2021
Anti-αβTCR antibody2018
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molec2016
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molec2016
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molec2014
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molec2014
Identification and characterization of function-blocking anti-ED-B-fibronectin a2010
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines2009
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines2009
Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitor2009
N-oxide anthranylamide derivatives and their use as medicaments2008